AWM
IDXX icon

Axxcess Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Axxcess Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,707
Closed -$1.15M – 678
2025
Q4 		$1.15M Buy
1,707
+465
+37% +$317K 0.02% 481
2025
Q3 		$794K Sell
1,242
-869
-41% -$527K 0.02% 499
2025
Q2 		$1.13M Sell
2,111
-552
-21% -$264K 0.03% 398
2025
Q1 		$1.12M Buy
2,663
+273
+11% +$119K 0.03% 366
2024
Q4 		$988K Sell
2,390
-440
-16% -$193K 0.02% 404
2024
Q3 		$1.43M Sell
2,830
-29
-1% -$14.1K 0.04% 322
2024
Q2 		$1.39M Buy
2,859
+464
+19% +$233K 0.04% 317
2024
Q1 		$1.29M Sell
2,395
-1,370
-36% -$749K 0.04% 325
2023
Q4 		$2.09M Buy
+3,765
New +$1.77M 0.06% 240
2022
Q2 		– Sell
-550
Closed -$301K – 597
2022
Q1 		$301K Sell
550
-10,269
-95% -$5.4M 0.02% 473
2021
Q4 		$7.12M Buy
+10,819
New +$6.79M 0.52% 41

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axxcess Wealth Management's IDXX Position: Q1 2026 in Review

Axxcess Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1,707 shares — an estimated $1.15M sold.

Axxcess Wealth Management first reported a position in IDXX in Q4 2021 and held it in 11 quarters. The position peaked at $7.12M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Axxcess Wealth Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Axxcess Wealth Management sold 1,707 Idexx Laboratories shares in Q1 2026, an estimated $1.15M.
  • Axxcess Wealth Management first reported a position in Idexx Laboratories in Q4 2021 and held it in 11 quarters.
  • Axxcess Wealth Management's Idexx Laboratories position peaked at $7.12M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Axxcess Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.